期刊名称:AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal

American Journal of Alzheimer's Disease and Other Dementias
American Journal of Alzheimer's Disease & Other Dementias® (AJA) is for professionals on the frontlines of Alzheimer's care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, administrators, and other healthcare specialists who manage patients with dementias and their families. Published six times per year, each issue offers practical information about medical, psychiatric, and nursing issues; diagnostic tools; psychosocial issues; clinical research; and administrative and legal issues. This journal is a member of the Committee on Publication Ethics (COPE)
Average time from submission to first decision: 35 days
2012 Impact Factor: 1.518
2012 Ranking: 127/191 in Clinical Neurology | 32/46 in Geriatrics & Gerontology Source: 2012 Journal Citation Reports ® (Thomson Reuters, 2013)
Clinically oriented advances for those on the frontlines of dementia care
American Journal of Alzheimer's Disease and Other Dementias® (AJADD) is for and by professionals on the frontlines of Alzheimer's care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, healthcare administrators, and other related healthcare specialists who deal with patients having dementias and families everyday. In every issue, you will find down-to-earth clinical information on
- Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia.
- New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias.
- Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences.
- Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process.
- Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.
By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to American Journal of Alzheimer's Disease and Other Dementias® today!
This journal is a member of the Committee on Publication Ethics (COPE).
Aims & Scope
American Journal of Alzheimer's Disease and other Dementias® offers physicians, nurses, psychiatrists, nursing home and assisted living administrators, and other healthcare professionals who deal with patients with dementias and their families everyday, a multi-disciplinary international forum for original research, case studies, and media reviews on behavior management, brain research, caregiving, communication strategies, evaluation, heredity, long-term care, memory loss, pharmacotherapy, psychosocial issues, recreation and activity therapy, restraint-free care, special care units, and symptom management.
Abstracting/indexing
CINAHL
Current Contents: Clinical Medicine
Index Medicus
MEDLINE
NISC
PsycINFO
SafetyLit
Science Citation Index Expanded (Web of Science)
SciSearch
Scopus
Instructions to Authors
Manuscript Preparation and Submission
1. General Considerations
Manuscripts should be submitted to http://mc.manuscriptcentral.com/ajad
Average time from submission to first decision: 35 days
Files should be submitted in Microsoft Word and should include the following elements: complete author names, author contact information, author credentials and affiliations, acknowledgments, abstract (150 words or less), keywords, references, tables, illustrations, and legends. The format and style of the manuscript should follow the guidelines of AMA manual of style (10th ed.).
For details of manuscript preparation not covered herein, please examine recent issues of the Journal.
2. Submission Process
User Account – The Manuscript Central program asks authors to generate an author/reviewer account if one has not been created already. Authors are required to supply their first and last names, email addresses, and keywords chosen from a list of those used previously in the Journal.
Title, Abstract, and Keywords – Authors first supply the manuscript title and an abstract. The title should be reasonably short and communicate the main idea of the research. The abstract should not be longer than 150 words and should substantively summarize the article. Five keywords to facilitate electronic access to this manuscript should be listed after the abstract. Given that researchers increasingly rely upon Google Scholar and other search engines, choice of appropriate keywords is imperative to encourage downloads and citations.
Tables and Figures: All figures and tables should be titled and numbered Tables should be placed at the end of the file, following text and references, with callouts for each in the text. Elements in tables should be separated by tabs, not cells or lines. High-resolution figures should be uploaded as separate electronic files, with callouts for each in the text. Acceptable file formats for figures include TIFF, EPS, and JPEG, and PDF Microsoft Application Files are acceptable for vector art (line art). (Please do not send glossies).
3. References
Authors are responsible for correctness and completeness of references. References should be typed double-spaced on a separate sheet of paper. They must be numbered consecutively in the order in which they appear in the text by superscript Arabic numerals. References should not include any unpublished observations or personal communications. References should be typed in the style adopted by the American Medical Association, listing up to 6 authors. For example, a standard journal article:
Schoni, MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr. 2000;19:79-85
4. Permission Guidelines
Authors are solely responsible for obtaining all necessary permissions and for paying any associated fees. Permission must be granted in writing by the copyright holder and must accompany the submitted manuscript. Authors are responsible for the accuracy of facts, opinions, and interpretations expressed in the article.
All published materials are copyrighted by Sage Publications, Inc. Every lead author must sign an electronic contract before an article can be published.
Authors who would like to refine the use of English in their manuscripts might consider using the services of a professional English-language editing company. We highlight some of these companies at http://www.sagepub.com/journalgateway/engLang.htm.
Please be aware that SAGE has no affiliation with these companies and makes no endorsement of them. An author's use of these services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and the particular company, and any costs incurred are the sole responsibility of the author.
For more details, please review the submission guidelines.
Inquiries may be directed to:
Sara Lippa, PhD
Managing Editor, The American Journal of Alzheimer's Disease and Other Dementias
16 Radcliff Road, Bala Cynwyd
PA 19004
610-667-9549
saralippa@gmail.com
Submissions should be sent to: http://mc.manuscriptcentral.com/ajad
Editorial Board
Editor-in-Chief:
Managing Editor:
Editorial Board Members:
| Myra Aud |
Assistant Professor, Sinclair School of Nursing, University of Missouri--Columbia |
| Alan Foldi |
PreProf., Dept. of Physiology and Biophysics (Nova Scotia) |
| Judith R. O'Jile, PhD |
Assistant Professor and Director, Neuropsychology Lab., Division of Psychology, Dept of Psychiatry and Human Behavior |
| Rebecca Sleeper, Pharm D |
Assistant Professor of Pharmacy Practice, Geriatrics, Texas Tech University Health Sciences Center, School of Pharmacy |
|